Literature DB >> 2460747

Differential expression of type-specific c-abl mRNAs in mouse tissues and cell lines.

M W Renshaw1, M A Capozza, J Y Wang.   

Abstract

The mammalian c-abl proto-oncogene produces mRNAs with 5' heterogeneity from two distinct promoters and the alternative splicing of variable 5' exons. By using quantitative RNase protection assays, the relative abundance of two major c-abl mRNAs, type I and type IV, in several mouse tissues and cell lines has been determined. Our results demonstrate that the level of type IV c-abl mRNA is rather constant, whereas that of the type I mRNA varies over a 10-fold range in different tissues and cell types. This finding has interesting implications for the function of the two c-abl proteins.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2460747      PMCID: PMC365533          DOI: 10.1128/mcb.8.10.4547-4551.1988

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  18 in total

1.  Murine B cell leukemia line with inducible surface immunoglobulin expression.

Authors:  C J Paige; P W Kincade; P Ralph
Journal:  J Immunol       Date:  1978-08       Impact factor: 5.422

2.  Cell-specific antigens and immunoglobulin synthesis of murine myeloma cells and their variants.

Authors:  R Hyman; P Ralph; S Sarkar
Journal:  J Natl Cancer Inst       Date:  1972-01       Impact factor: 13.506

3.  Mouse myelomas and lymphomas in culture.

Authors:  K Horibata; A W Harris
Journal:  Exp Cell Res       Date:  1970-04       Impact factor: 3.905

Review 4.  Alternative splicing: a ubiquitous mechanism for the generation of multiple protein isoforms from single genes.

Authors:  R E Breitbart; A Andreadis; B Nadal-Ginard
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

5.  Differential expression of cellular oncogenes during pre- and postnatal development of the mouse.

Authors:  R Müller; D J Slamon; J M Tremblay; M J Cline; I M Verma
Journal:  Nature       Date:  1982-10-14       Impact factor: 49.962

6.  Identification of two distinct regulatory regions adjacent to the human beta-interferon gene.

Authors:  K Zinn; D DiMaio; T Maniatis
Journal:  Cell       Date:  1983-10       Impact factor: 41.582

7.  The mouse c-abl locus: molecular cloning and characterization.

Authors:  J Y Wang; F Ledley; S Goff; R Lee; Y Groner; D Baltimore
Journal:  Cell       Date:  1984-02       Impact factor: 41.582

8.  Karyotypic, virologic, and immunologic analyses of two continuous lymphocyte lines established from New Zealand black mice: possible relationship of chromosomal mosaicism to autoimmunity.

Authors:  R A Lerner; F Jensen; S J Kennel; F J Dixon; G Des Roches; U Francke
Journal:  Proc Natl Acad Sci U S A       Date:  1972-10       Impact factor: 11.205

9.  Structure of the Abelson murine leukemia virus genome and the homologous cellular gene: studies with cloned viral DNA.

Authors:  S P Goff; E Gilboa; O N Witte; D Baltimore
Journal:  Cell       Date:  1980-12       Impact factor: 41.582

10.  Cellular RNA homologous to the Abelson murine leukemia virus transforming gene: expression and relationship to the viral sequence.

Authors:  J Y Wang; D Baltimore
Journal:  Mol Cell Biol       Date:  1983-05       Impact factor: 4.272

View more
  12 in total

1.  The complete coding sequence of arg defines the Abelson subfamily of cytoplasmic tyrosine kinases.

Authors:  G D Kruh; R Perego; T Miki; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

2.  Recombinant tumor necrosis factor alpha and interleukin 1 alpha increase expression of c-abl protooncogene mRNA in cultured human marrow stromal cells.

Authors:  D F Andrews; J J Nemunaitis; J W Singer
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

3.  Expression of protooncogene-encoded mRNA by colonic epithelial cells in inflammatory bowel disease.

Authors:  R J Alexander; A Panja; E Kaplan-Liss; L Mayer; R F Raicht
Journal:  Dig Dis Sci       Date:  1996-04       Impact factor: 3.199

4.  Targeted gene disruption of the endogenous c-abl locus by homologous recombination with DNA encoding a selectable fusion protein.

Authors:  P L Schwartzberg; E J Robertson; S P Goff
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

5.  Rapid activation of the T-cell tyrosine protein kinase pp56lck by the CD45 phosphotyrosine phosphatase.

Authors:  T Mustelin; K M Coggeshall; A Altman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

6.  Alternative processing of mRNAs encoding mammalian chromosomal high-mobility-group proteins HMG-I and HMG-Y.

Authors:  K R Johnson; D A Lehn; R Reeves
Journal:  Mol Cell Biol       Date:  1989-05       Impact factor: 4.272

7.  Progressive de novo DNA methylation at the bcr-abl locus in the course of chronic myelogenous leukemia.

Authors:  M Zion; D Ben-Yehuda; A Avraham; O Cohen; M Wetzler; D Melloul; Y Ben-Neriah
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

8.  Two distinct forms of M-locus protein kinase localize to the plasma membrane and interact directly with S-locus receptor kinase to transduce self-incompatibility signaling in Brassica rapa.

Authors:  Mitsuru Kakita; Kohji Murase; Megumi Iwano; Tomohito Matsumoto; Masao Watanabe; Hiroshi Shiba; Akira Isogai; Seiji Takayama
Journal:  Plant Cell       Date:  2007-12-07       Impact factor: 11.277

9.  Two amino acid residues confer different binding affinities of Abelson family kinase SRC homology 2 domains for phosphorylated cortactin.

Authors:  Stacey M Gifford; Weizhi Liu; Christopher C Mader; Tiffany L Halo; Kazuya Machida; Titus J Boggon; Anthony J Koleske
Journal:  J Biol Chem       Date:  2014-06-02       Impact factor: 5.157

10.  The cytostatic function of c-Abl is controlled by multiple nuclear localization signals and requires the p53 and Rb tumor suppressor gene products.

Authors:  S T Wen; P K Jackson; R A Van Etten
Journal:  EMBO J       Date:  1996-04-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.